Dr. Dorraji is a highly experienced cancer immunologist focusing on cell and antibody therapies. He currently serves as a co-founder of a preclinical stage company in Oslo, a Scientific Advisor at Guidepoint, and an Innovation Project leader at SPARK Norway, UiO:Life Science. Dr. Dorraji is also a researcher and former postdoc at the Immunotherapy against solid cancers Group, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital.Dr. Dorraji holds a PhD in Immunology from The University of Tromsø and a Master of Science in Medical Cell Biology from The University of Bergen. His extensive background includes roles as a laboratory research technician and scientific congress and meeting advisor.He has several patents in cancer immunology, including HER2 VARIANT CAR and antibody, P95HER2 antibody variants, and two more patent applications in preparation. Dr. Dorraji has received numerous grants and awards, such as the Novo Nordisk Pioneer Innovator Grant, Innovation Grants from Norwegian Heath Region South-East and SPARK Norway, UiO:Life Science, and a Research Grant from the 7th National PhD Conference in Medical Imaging.

Dr. Neniskyte is a skilled and accomplished Principal Investigator and Group Leader at the Partnership Institute of European Molecular Biology Laboratory and Life Sciences Center, Vilnius University, Lithuania.With a rich educational background, she earned her PhD in Biochemistry from St. John's College, University of Cambridge, UK, and her MSc and BSc in Biochemistry from Vilnius University, Lithuania. She has held various positions, including a Marie Sklodowska Curie Researcher and Principal Investigator, Postdoctoral Marie Curie Fellow, and Research Associate at esteemed institutions in Lithuania, Italy, and the UK. She also has secured research funding from several sources, including the European Regional Development Fund and Vilnius University Science Advancement Fund.Dr. Neniskyte has contributed significantly to biochemistry and neuroscience as an author of multiple research publications. She has also filed a patent application for a genetically encoded Lact-fluor biomarker system for visualizing phosphatidylserine.

Dr. Jones was born and trained in the United States. He earned his doctorate in Molecular Biology, Cellular Biology and Biochemistry at Brown University with Dr. Richard Bennett. He produced his postdoctoral research in CRISPR biochemistry and cellular aging with Dr. Ilya Finkelstein at the University of Texas. In 2021, he established his research group at the EMBL Partnership Institute in Vilnius University's Life Sciences Center, where he leads the group in their search to discover and characterize CRISPR and other programmable nucleases with next-generation biochemistry.​Stephen lives in Vilnius, Lithuania, with his wife, Eva and their greyhound, Audrey Sparkles. Beyond science, Stephen is also a musician, mechanic, adventurer and lover of life.

Patrick obtained his PhD from Philipps University Marburg, Germany, after which he pursued a Postdoc at UC Berkeley, USA, before leading the Pausch Lab at the VU LSC-EMBL Partnership Institute for Genome Editing Technologies in Vilnius, Lithuania. During his PhD and postdoctoral work, Patrick investigated a range of nucleic acid interacting stress response factors and adaptive immune systems from bacteria, also contributing to developing novel CRISPR genome editing tools derived from jumbo bacteriophages.Beyond science, Patrick enjoys cycling in and around Vilnius and occasionally tours on his motorcycle. Patrick's other passions are traveling and rock climbing.